Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence (Q26753183)

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Global distribution and prevalence of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Prevalence and significance of antibodies to hepatitis c virus among Saudi haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C).

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Interspousal and intrafamilial transmission of hepatitis C virus: a myth or a concern?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Global epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary haemolytic anaemias

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Infection with hepatitis viruses (B and C) and human retroviruses (HTLV-1 and HIV) in Saudi children receiving cycled cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

beta-Thalassaemia major in Kuwait

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Epidemiology of HIV infection in the Middle East and North Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Risk of hepatitis C virus infection among household contacts of Saudi patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

HCV burden of infection in Egypt: results from a nationwide survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis C virus antibodies in high-risk Saudi groups

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Seropositivity to hepatitis C virus in Saudi haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis C virus antibody in Kuwait

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis C antibodies among blood donors in Qatar

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Is dialysis environment more important than blood transfusion in transmission of hepatitis C virus during hemodialysis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Evolving epidemiology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Prevalence of viral markers among first-time Arab blood donors in Kuwait.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Decline in hepatitis B infection in sickle cell anaemia and beta thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis C in chronic renal failure patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Importing health conditions of expatriate workers into the United Arab Emirates

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Transformations Related to the Angular and the Square Root

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Disease markers in blood donors at King Fahad Hospital, Al Baha.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Hepatitis C virus (HCV) infection in Saudi Arabia: A review

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

Viral hepatitis B and C in HIV-infected patients in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJID.2016.03.012

7 January 2021